Recent Events & Catalysts
Viridian Therapeutics, Inc. (VRDN) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
RBC Capital Maintains Outperform on Viridian Therapeutics, Raises Price Target to $36
Benzinga · 4d ago
Truist Securities Maintains Buy on Viridian Therapeutics, Raises Price Target to $39
Benzinga · 4d ago
Viridian Therapeutics Q2 EPS $(1.05) Misses $(1.02) Estimate, Sales $233.000K Beat $22.308K Estimate
Benzinga · 5d ago
Amgen: First $10 Billion Quarter, More Growth Ahead
SeekingAlpha · 6d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-06 · 6d ago · Material
Regulation FD disclosure, Other events, Financial statements and exhibits
Filed 2026-06-29 · 44d ago
Submission of matters to a vote of security holders
Filed 2026-06-03 · 70d ago
Termination of a material agreement
Filed 2026-05-28 · 76d ago
Entry into a material agreement
Filed 2026-05-26 · 78d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.